Ti trovi qui: Home » International news

Te.Far.Ti nanomedicine group is granted again a new international financing. The object of the study is glioblastoma, a malignant type of brain cancer.

Te.Far.T.I. Nanomedicine research group of the Department of Life Sciences at Unimore has received a new financing for the study of a project focused on Nanomedicine for overcoming the blood-brain barrier in Cancer Pathologies of the Central Nervous System. The research by the Unimore group will be financed thanks to the new call for applications of the Ministry of Foreign Affairs and International Cooperation (MAECI) for gathering joint research projects of major importance between Italy and the US, within the Scientific and Technologic Cooperation Programme between Italy and the US for the period 2019-2021.

The objective of the study carried out by Unimore researchers, which will be developed by Te.Far.Ti group at Unimore made of professors Giovanni TosiBarbara RuoziMaria Angela Vandelli and Flavio Forni of the Department of Life Science, in collaboration with professor Robert K. Prud'homme of the Department of Chemical & Biological Engineering at Princeton University, is to develop new drugs targeted to glioblastoma, a malignant type of brain cancer that is characterised by a poor prognosis and currently lacks an effective treatment. The project also provides for the financing of a research grant for a young researcher dedicated to this study, as well as the support of research activities.

Professor Giovanni Tosi, project manager and coordinator of the platform of Nanomedicine at Unimore, and scientific responsible for Unimore inside the European Technology Platform for Nanomedicine, remarks that “We are clearly very proud of the results achieved and the confidence that both the Italian and US Ministries have placed on us, in a project like this one, focused on innovations in applied pharmaceutical technology and pathologies of the Central Nervous System, which we have been dealing with for many years as a research group. This project places the University of Modena and Reggio Emilia and nanomedicine on the front line as regards new strategies in the field of treatments, allowing for consolidating a relationship with a prestigious university like the Princeton University. We hope to be successful and therefore be able to offer new opportunities for the treatment of pathologies like glioblastoma, for which there are no final treatments”.

The call for applications, which supports projects of major importance in the field of health and life sciences, more specifically in the field precision medicine in oncology and innovative biotechnologies and technologies for the health, provides for an annual co-financing by the Italian Government, exclusively addressed to projects of great relevance for the two countries.

Categorie: International - english

Articolo pubblicato da: Ufficio Stampa Unimore - ufficiostampa@unimore.it